CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 22.44
+0.08 (0.36%)
Jun 18, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 9.6 billion as of June 18, 2026. Its market cap has decreased by -15.15% in one year.
Market Cap
9.60B
Enterprise Value
8.18B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
22.44
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 9.60B, an increase of 26.76%. That is a compound annual growth rate of 3.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 9.60B | -24.02% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fujian Haixi Pharmaceuticals | 13.58B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Consun Pharmaceutical Group | 11.21B |
| Xuanzhu Biopharmaceutical | 8.68B |
| Shandong Xinhua Pharmaceutical Company | 8.03B |
| Luye Pharma Group | 7.91B |
| Sihuan Pharmaceutical Holdings Group | 7.87B |
| CF PharmTech | 7.72B |